Further, no significant difference in the frequency of PM2K+CD14+ or PM2K+CD14− subset was found between mild/moderate and severe/very severe groups (Fig. 3c), or between well-control [asthma control test (ACT) score ≥20] and poor-control (ACT score < 20) cases (Fig. 3d). This evidence concerns the gene CD14 and asthma.